Effectiveness of pantocrinum in the complex treatment of chronic kidney disease
Journal Title: Нирки - Year 2016, Vol 3, Issue 17
Abstract
The dynamics of chronic renal disease is presented for 25 patients, taking into account the effectiveness of Pantocrine. The study involved patients with chronic renal disease from I to V stages of different nosological reasons. The duration of the study was 8 weeks and treatment efficacy was weekly estimated. Effectiveness was assessed using the following criteria: general weakness, fatigue, exhaustion, sense of vitality and energy. According to obtained data, the effectiveness of Pantocrine in a complex treatment could be observed already from the first week of therapy. The assessment criteria used in this study show that after four weeks of treatment 20 % of patients did not experience general weakness, 40 % experienced slight general weakness, 28 % of patients did not experience fatigue and exhaustion, 40 % of patients felt burst of energy and revitalization most of the time. In addition, some of patients have noticed decrease of anxiety, despondency and depression; patients prone to hypotension observed normalization of blood pressure. Pantocrine is recommended to be included into treatment of patients with chronic renal disease.
Authors and Affiliations
N. O. Kolomiychuk
Keywords
Related Articles
- EP ID EP208324
- DOI 10.22141/2307-1257.3.17.2016.76456
- Views 89
- Downloads 0
International Course of Postgraduate Education REENA™ «Clinical Case in Nephrology»
The review of key lectures which were presented on the international course of postgraduate education REENA™ “Clinical case in nephrology” on September’16th, 2016 in Irpen, Ukraine, is presented in the article.
Nephrotic Syndrome or Paraneoplastic Nephropathy in Shereshevsky — Turner Syndrome?
.
Precision diagnosis of lupus nephritis: opportunities and role of biomarkers
The most common complication in patients with systemic lupus erythematosus is lupus nephritis (LN), a condition that can lead to end-stage kidney disease. In recent years, many serum and urine biomarkers, genetic studies...
Renin-Angiotensin System Blockers and Renal Functional Reserve. Is There a Limit of Renoprotection?
Renin-angiotensin system (RAS) blockers (angiotensin converting enzyme inhibitors, angiotensin receptor blockers, direct renin inhibitor) have a renoprotective effect in the presence of preserved glomerular filtration ra...
National Guidelines «Acute Kidney Injury: Basic Principles of the Diagnosis, Prevention and Treatment (2015)» Part II
The main problems of acute kidney injury (AKI) are considered. The necessity of introduction of the AKI concept into the practice of national health care is justified. Specific recommendations for the diagnosis, monitori...